[Interest in Avastin in digestive and hepatobiliary surgery and optimization of its use in practice].
Mariani
P
P
Unité de chirurgie digestive, Institut Curie, Paris. pascale.mariani@curie.net
D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001662:Biliary Tract Surgical Procedures; D013505:Digestive System Surgical Procedures; D006498:Hepatectomy; D006801:Humans; D008099:Liver / Q000601:surgery
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab